Metabolic Associated Fatty Liver Disease (MAFLD) Associated with Diabetes Mellitus, Overweight, and Metabolic Dysregulation as an Inflammatory Cascade
(2023). Metabolic Associated Fatty Liver Disease (MAFLD) Associated with Diabetes Mellitus, Overweight, and Metabolic Dysregulation as an Inflammatory Cascade. EKB Journal Management System, 3(2), -. doi: 10.21608/esdlj.2023.456203
. "Metabolic Associated Fatty Liver Disease (MAFLD) Associated with Diabetes Mellitus, Overweight, and Metabolic Dysregulation as an Inflammatory Cascade". EKB Journal Management System, 3, 2, 2023, -. doi: 10.21608/esdlj.2023.456203
(2023). 'Metabolic Associated Fatty Liver Disease (MAFLD) Associated with Diabetes Mellitus, Overweight, and Metabolic Dysregulation as an Inflammatory Cascade', EKB Journal Management System, 3(2), pp. -. doi: 10.21608/esdlj.2023.456203
Metabolic Associated Fatty Liver Disease (MAFLD) Associated with Diabetes Mellitus, Overweight, and Metabolic Dysregulation as an Inflammatory Cascade. EKB Journal Management System, 2023; 3(2): -. doi: 10.21608/esdlj.2023.456203

Metabolic Associated Fatty Liver Disease (MAFLD) Associated with Diabetes Mellitus, Overweight, and Metabolic Dysregulation as an Inflammatory Cascade

Egyptian Society of Diabetes and Lipidology Journal
Volume 3, Issue 2, October 2023    PDF (821.65 K)
Document Type: Abstracts
DOI: 10.21608/esdlj.2023.456203
Abstract
Metabolic Associated Faty Liver Disease, MAFLD, is a new nomenclature proposed to replace the old term NAFLD. MAFLD is a new challenge in modern medicine, due to its progressively increasing global prevalence and its associated multiple sequels. The diagnosis of MAFLD relied upon on presence of both hepatic steatosis and any of the following three metabolic conditions: overweight/obesity, type 2 diabetes mellitus, or evidence of metabolic dysregulation (MD) in lean 
individuals.
Statistics
Article View: 30
PDF Download: 10